Genome-Wide Molecular Profiling Informs Therapy for Recurrent Glioblastoma

Scientists report that several patients with recurring glioblastoma survived for more than a year in a clinical trial the researchers believe was the first to use DNA and RNA sequencing of a patient's tumor to provide treatment for these patients in real time. The study (“Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma”), published in Clinical Cancer Research , was led by the Translational Genomics Research Institute (